newsfilter
← Latest News
GlobeNewswire·

AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), ("AzurRx" or the "Company"), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal